Immune Checkpoint Inhibitors Change Treatment Landscape for Metastatic Cervical CancerByFendi Jan, PharmD,Amy Indorf, PharmD, BCOP,Allison Kupsh, PharmDFebruary 8th 2023Approval of a novel antibody-drug conjugate ushers in new second-line option.